Uncategorized

Israeli FemTech Company MobileODT Is Supporting a Large Scale Government Cervical Cancer Screening Project in the Dominican Republic

Israeli femtech company MobileODT, who are innovating in cervical cancer screening, have announced that their Visual Check AI technology is supporting a large-scale government cervical cancer screening project in the Dominican Republic. This proof of concept project was initiated as part of the company’s strategic direction in providing cervical cancer screening at scale, utilizing Artificial Intelligence (AI) and Machine Learning (ML) capabilities. The…

Natera and Tesis Labs Announce Strategic Collaboration on Prenatal Genetic Testing

Natera, a global leader in non-invasive genetic testing and analysis of cfDNA, and Tesis Labs, a US multi-region lab services provider with labs in Colorado, Texas and Arizona, announced a strategic partnership in the field of prenatal genetic testing. The collaboration will allow Tesis to broaden its portfolio of genetic testing offerings and participate in the fast growing screening market for over 4 million pregnancies in the…

Cleo Raises a $40M Series C to Fuel Growth & Launch New Products for Working Families and Their Employers

Cleo, a leading family benefits platform supporting working families in the planning stage through the teenage years, today announced a $40 million Series C investment led by Transformation Capital, with participation from Glynn Capital, PruVen Capital and Gaingels and existing investors Greylock, NEA and Felicis. In conjunction with this round, Transformation Capital Managing Partner, Mike Dixon will join Cleo’s Board. This round…

Béa Fertility Raises £800K to Bring At-Home Fertility Treatments to the UK

Healthcare startup Béa Fertility has announced a £800K raise to bring a pioneering at-home fertility treatment to the UK. The round was led by Calm/Storm VC and joined by Q Ventures, and includes an innovation grant from the recent InnovateUK SMART competition.  Founded by embryologist David O’Rourke and femtech specialist Tess Cosad, Béa Fertility is focused on democratising access to affordable, effective…

Women’s Health Startup Maven Launches MavenRx, a Fertility Drug Delivery Service to Further Strengthen Its Fertility Program

Women’s and Family Health Startup Maven has announced the expansion of its award-winning fertility program with the launch of MavenRx. Through partnerships with two specialty pharmacies, Maven members can now receive industry-leading price discounts on their medications, complimentary same-day or next-day shipping nationwide, and on-demand, pharmacist-led unboxing and injection support. MavenRx adds a critical layer of support for all U.S.-based employees covered…

UK-based Femtech Startup Hertility Launches Tailored At-Home Testing to Address the COVID-Related Fertility Crisis

The knock-on effects of the pandemic that disrupted our lives in 2020 are still prevalent, despite the hopeful wishes of a “Happy New Year”. These disruptions, in particular, have affected those looking to plan a family. With many wedding plans postponed, dating lives interrupted or halted altogether, family plans have also been affected. Studies have shown that 6 in 10 women are anxious…

Report: A Decade in Review – Funding to the Female Founders (Crunchbase)

Crunchbase has recently published the new report “A Decade in Review – Funding to the Female Founders”. Women received a record amount of U.S. startup venture capital in 2019, according to recent figures. But while female founders securing 2.8 percent of total startup investment in the United States may be lauded as a historic achievement, it’s not something we should be complacent about.  A…